Krishna Institute of Medical Sciences Ltd. engages in the provision of medical and healthcare services. The company was founded by B. Bhaskar Rao on July 26, 1973 and is headquartered in Secunderabad, India.
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of KIMS is 570.15 INR — it has increased by 1.02% in the past 24 hours. Watch KRISHNA INST OF MED SCI L stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on NSE exchange KRISHNA INST OF MED SCI L stocks are traded under the ticker KIMS.
KIMS stock has risen by 3.66% compared to the previous week, the month change is a 4.81% rise, over the last year KRISHNA INST OF MED SCI L has showed a 52.45% increase.
We've gathered analysts' opinions on KRISHNA INST OF MED SCI L future price: according to them, KIMS price has a max estimate of 660.00 INR and a min estimate of 471.40 INR. Watch KIMS chart and read a more detailed KRISHNA INST OF MED SCI L stock forecast: see what analysts think of KRISHNA INST OF MED SCI L and suggest that you do with its stocks.
KIMS reached its all-time high on Sep 16, 2024 with the price of 580.00 INR, and its all-time low was 187.50 INR and was reached on Jul 1, 2021. View more price dynamics on KIMS chart. See other stocks reaching their highest and lowest prices.
KIMS stock is 3.31% volatile and has beta coefficient of 0.23. Track KRISHNA INST OF MED SCI L stock price on the chart and check out the list of the most volatile stocks — is KRISHNA INST OF MED SCI L there?
Today KRISHNA INST OF MED SCI L has the market capitalization of 228.16 B, it has increased by 3.38% over the last week.
KRISHNA INST OF MED SCI L is going to release the next earnings report on Nov 9, 2024. Keep track of upcoming events with our Earnings Calendar.
KIMS earnings for the last quarter are 2.20 INR per share, whereas the estimation was 1.97 INR resulting in a 11.86% surprise. The estimated earnings for the next quarter are 2.50 INR per share. See more details about KRISHNA INST OF MED SCI L earnings.
KRISHNA INST OF MED SCI L revenue for the last quarter amounts to 6.88 B INR, despite the estimated figure of 6.79 B INR. In the next quarter, revenue is expected to reach 7.47 B INR.
KIMS net income for the last quarter is 866.00 M INR, while the quarter before that showed 654.73 M INR of net income which accounts for 32.27% change. Track more KRISHNA INST OF MED SCI L financial stats to get the full picture.
No, KIMS doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Nov 10, 2024, the company has 6.09 K employees. See our rating of the largest employees — is KRISHNA INST OF MED SCI L on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. KRISHNA INST OF MED SCI L EBITDA is 6.63 B INR, and current EBITDA margin is 26.31%. See more stats in KRISHNA INST OF MED SCI L financial statements.
Like other stocks, KIMS shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade KRISHNA INST OF MED SCI L stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So KRISHNA INST OF MED SCI L technincal analysis shows the strong buy rating today, and its 1 week rating is strong buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating KRISHNA INST OF MED SCI L stock shows the buy signal. See more of KRISHNA INST OF MED SCI L technicals for a more comprehensive analysis. If you're still not sure, try looking for inspiration in our curated watchlists.